APA (7th ed.) Citation

M, D. W., A, G., D, H., D, M., C, P., S, A. D., . . . M, S. (2017). Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors. Molecular medicine (Cambridge, Mass.), 23, 50. https://doi.org/10.2119/molmed.2017.00011

Chicago Style (17th ed.) Citation

M, De Witt, et al. "Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors." Molecular Medicine (Cambridge, Mass.) 23 (2017): 50. https://doi.org/10.2119/molmed.2017.00011.

MLA (9th ed.) Citation

M, De Witt, et al. "Repurposing Mebendazole as a Replacement for Vincristine for the Treatment of Brain Tumors." Molecular Medicine (Cambridge, Mass.), vol. 23, 2017, p. 50, https://doi.org/10.2119/molmed.2017.00011.